117 related articles for article (PubMed ID: 9655476)
1. Specific binding of a 125I-secretoneurin analogue to a human monocytic cell line.
Schneitler C; Kähler C; Wiedermann CJ; Hogue-Angeletti R; Fischer-Colbrie R
J Neuroimmunol; 1998 Jun; 86(1):87-91. PubMed ID: 9655476
[TBL] [Abstract][Full Text] [Related]
2. Secretoneurin and chemoattractant receptor interactions.
Kong C; Gill BM; Rahimpour R; Xu L; Feldman RD; Xiao Q; McDonald TJ; Taupenot L; Mahata SK; Singh B; O'Connor DT; Kelvin DJ
J Neuroimmunol; 1998 Aug; 88(1-2):91-8. PubMed ID: 9688329
[TBL] [Abstract][Full Text] [Related]
3. The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro.
Kähler CM; Kaufmann G; Kähler ST; Wiedermann CJ
Regul Pept; 2002 Dec; 110(1):65-73. PubMed ID: 12468111
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
Wynick D; Smith DM; Ghatei M; Akinsanya K; Bhogal R; Purkiss P; Byfield P; Yanaihara N; Bloom SR
Proc Natl Acad Sci U S A; 1993 May; 90(9):4231-5. PubMed ID: 7683428
[TBL] [Abstract][Full Text] [Related]
5. Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin.
Schratzberger P; Reinisch N; Kähler CM; Wiedermann CJ
Regul Pept; 1996 Jul; 63(2-3):65-71. PubMed ID: 8837212
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors.
Turquier V; Yon L; Grumolato L; Alexandre D; Fournier A; Vaudry H; Anouar Y
Mol Pharmacol; 2001 Jul; 60(1):42-52. PubMed ID: 11408599
[TBL] [Abstract][Full Text] [Related]
7. Secretoneurin: a functional neuropeptide in health and disease.
Wiedermann CJ
Peptides; 2000 Aug; 21(8):1289-98. PubMed ID: 11035217
[TBL] [Abstract][Full Text] [Related]
8. Sensory neuropeptides are potent chemoattractants for human basophils in vitro.
Cima K; Vogelsinger H; Kähler CM
Regul Pept; 2010 Feb; 160(1-3):42-8. PubMed ID: 20035805
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro.
Kähler CM; Kirchmair R; Kaufmann G; Kähler ST; Reinisch N; Fischer-Colbrie R; Hogue-Angeletti R; Winkler H; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):932-9. PubMed ID: 9157958
[TBL] [Abstract][Full Text] [Related]
10. Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.
Beaujouan JC; Torrens Y; Saffroy M; Glowinski J
Neuroscience; 1986 Aug; 18(4):857-75. PubMed ID: 2429231
[TBL] [Abstract][Full Text] [Related]
11. Evidence for specific N-terminal galanin fragment binding sites in the rat brain.
Hedlund PB; Yanaihara N; Fuxe K
Eur J Pharmacol; 1992 Dec; 224(2-3):203-5. PubMed ID: 1281778
[TBL] [Abstract][Full Text] [Related]
12. Secretoneurin is a secretogranin-2 derived hormonal peptide in vertebrate neuroendocrine systems.
Mitchell K; Mikwar M; Da Fonte D; Lu C; Tao B; Peng D; Erandani WKCU; Hu W; Trudeau VL
Gen Comp Endocrinol; 2020 Dec; 299():113588. PubMed ID: 32828813
[TBL] [Abstract][Full Text] [Related]
13. Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils.
Dunzendorfer S; Schratzberger P; Reinisch N; Kähler CM; Wiedermann CJ
Blood; 1998 Mar; 91(5):1527-32. PubMed ID: 9473216
[TBL] [Abstract][Full Text] [Related]
14. A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro.
Kähler CM; Kaufmann G; Hogue-Angeletti R; Fischer-Colbrie R; Dunzendorfer S; Reinisch N; Wiedermann CJ
Eur J Pharmacol; 1999 Jan; 365(1):65-75. PubMed ID: 9988125
[TBL] [Abstract][Full Text] [Related]
15. Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
Chatterjee TK; Fisher RA
Mol Pharmacol; 1991 Jun; 39(6):798-804. PubMed ID: 1646951
[TBL] [Abstract][Full Text] [Related]
16. Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines.
Wang JM; McVicar DW; Oppenheim JJ; Kelvin DJ
J Exp Med; 1993 Mar; 177(3):699-705. PubMed ID: 7679707
[TBL] [Abstract][Full Text] [Related]
17. Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro.
Kähler CM; Schratzberger P; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2029-35. PubMed ID: 9351368
[TBL] [Abstract][Full Text] [Related]
18. Characterization and developmental evolution of a high-affinity binding site for calcitonin gene-related peptide on chick skeletal muscle membrane.
Roa M; Changeux JP
Neuroscience; 1991; 41(2-3):563-70. PubMed ID: 1651462
[TBL] [Abstract][Full Text] [Related]
19. Sortilin is expressed in cultured human keratinocytes and is regulated by cutaneous neuropeptides.
Kiss M; Dallos A; Kormos B; Sántha P; Dobozy A; Husz S; Kemény L
J Invest Dermatol; 2010 Nov; 130(11):2553-60. PubMed ID: 20613775
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic analysis of binding sites for 125I-Bolton-Hunter-substance P in the human eye.
Kieselbach GF; Ragaut R; Knaus HG; König P; Wiedermann CJ
Peptides; 1990; 11(4):655-9. PubMed ID: 1700397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
